IP Library Assignment 070274/0675
Patent Assignment
Reel/Frame 070274/0675

Change of Address

Recorded: 2025-02-20 Pages: 9
Assignor
BALTICGRUPPEN BIO AB
Executed: 2019-05-03
Assignee
BALTICGRUPPEN BIO AB
TVISTEVAGEN 47C, UMEA, 907 29, SWEDEN
Covered Properties (2)
1,2,4-Thiazoloidin-3-One Derivatives and Their Use in the Treatment of Cancer
Patent: 9,162,994 →
Application: 13/381,426 →
Publication: US 2012/0183537
1,2,4-Thiazolidin-3-One Derivatives and Their Use in the Treatment of Cancer
Patent: 9,675,596 →
Application: 14/883,190 →
Publication: US 2016/0128993
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 4, 2012
From: WESTMAN, JACOB; HALLETT, ALLAN; VAGBERG, JAN
To: BETAGENON AB
Reel/Frame 027985/0965 →
Assignment of Assignor's Interest Dec 10, 2015
From: WESTMAN, JACOB; HALLETT, ALLAN; VAGBERG, JAN
To: BETAGENON AB
Reel/Frame 037262/0569 →
Assignment of Assignor's Interest Jan 22, 2016
From: BETAGENON AB
To: BALTIC BIO AB
Reel/Frame 037560/0337 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 37560 Frame 337. Assignor(S) Hereby Confirms the Assignment. Jun 27, 2024
From: AB, BETAGENON
To: BALTICGRUPPEN BIO AB
Reel/Frame 068654/0045 →
Confirmatory Assignment Nov 8, 2024
From: BETAGENON AB
To: BALTICGRUPPEN BIO AB
Reel/Frame 069333/0078 →
Change of Name Dec 11, 2024
From: BALTICGRUPPEN BIO AB
To: BETAGENON AB
Reel/Frame 069887/0919 →
Change of Address Dec 11, 2024
From: BALTICGRUPPEN BIO AB
To: BALTICGRUPPEN BIO AB
Reel/Frame 069715/0586 →
Change of Address Dec 11, 2024
From: BETAGENON AB
To: BETAGENON AB
Reel/Frame 069590/0703 →